Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in IndiaPRNewsWire • 12/28/21
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Novavax (NVAX) Investors Jan. 11th Deadline in Securities Class Action, Encourages Investors with Losses to Contact Firm's AttorneysNewsfile Corp • 12/27/21
Kessler Topaz Meltzer & Check, LLP Reminds Novavax, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the FirmNewsfile Corp • 12/26/21
NVAX CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Announces to Novavax, Inc. of Deadline in Securities Fraud Class Action LawsuitPRNewsWire • 12/24/21
Novavax Announces Initial Omicron Cross-Reactivity Data from COVID-19 Vaccine Booster and Adolescent StudiesPRNewsWire • 12/22/21
NOVAVAX, INC. (NVAX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Novavax, Inc.Newsfile Corp • 12/22/21
Novavax Has Finally Received The Much-Awaited Approval And The Stock Is Set To SoarInvestorPlace • 12/22/21
Thornton Law Firm Reminds Novavax, Inc. (NVAX) Investors of Securities Class Action LawsuitNewsfile Corp • 12/22/21